Model for end-stage liver disease correlates with disease relapse and death of patients with Merkel cell carcinoma

  • Merkel cell carcinoma (MCC) is a highly malignant skin tumor that occurs mainly in elderly and/or immunosuppressed patients. MCC prognosis has been significantly improved by the introduction of immune checkpoint inhibitor treatment. Recently, blood-based biomarkers have been investigated that can potentially predict the outcome of MCC patients. In this context, parameters of liver scores have not yet been investigated. We retrospectively recruited 47 MCC patients with available relevant laboratory data at primary diagnosis. At this time, we investigated blood-based scores as follows: model for end-stage liver disease (MELD), aspartate aminotransferase/platelet count ratio index (APRI), and the alanine transaminase/aspartate aminotransferase ratio (De Ritis ratio). MCC relapse was negatively correlated with the De Ritis score (r = −0.3, \(\it p\) = 0.024) and positively correlated with the MELD score (r = 0.3, \(\it p\) = 0.035). Moreover, MCC-specific death positively correlated with CCI score (r = 0.4, \(\it p\) = 0.01) and MELD score (r = 0.4, \(\it p\) = 0.003). In multivariable analysis, the MELD score remained in the regression model as significant independent predictor for MCC relapse (hazard ratio: 1.16 (95% CI 1.04 to 1.29; \(\it p\) = 0.008) and MCC-specific death (hazard ratio: 1.2 (95% CI 1.04 to 1.3; \(\it p\) = 0.009). We observed for the first time that the MELD score appears to independently predict both MCC relapse and MCC-specific death. These results should be further investigated in larger prospective studies.

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Author:Thilo GambichlerORCiDGND, Jürgen C. BeckerORCiDGND, Laura SusokGND, Riina KäpynenGND, Nessr Abu RachedORCiDGND
Parent Title (English):Cancers
Place of publication:Basel
Document Type:Article
Date of Publication (online):2024/01/30
Date of first Publication:2023/06/15
Publishing Institution:Ruhr-Universität Bochum, Universitätsbibliothek
Tag:Open Access Fonds
APRI-score; De Ritis; MCC; MELD; biomarkers; carcinoma; liver; neuroendocrine; skin cancer; tumor metabolism
Issue:12, Article 3195
First Page:3195-1
Last Page:3195-9
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Fund of Ruhr-Universität Bochum.
Institutes/Facilities:Katholisches Klinikum Bochum, Dermatologie, Venerologie und Allergologie
Dewey Decimal Classification:Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit
open_access (DINI-Set):open_access
Licence (English):License LogoCreative Commons - CC BY 4.0 - Attribution 4.0 International